52P Real-world efficacy and safety of trastuzumab deruxtecan in heavily pre-treated HER2-low metastatic breast cancer with distinct IHC statuses: Evidence from a Chinese population

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of Oncology

Topics

Medicine

Cancer Oncology

Internal Medicine

Radiology, Nuclear Medicine And Imaging

Trastuzumab

Show all topics

DOI

10.1016/j.annonc.2024.10.073